⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DRMA News
Dermata Therapeutics, Inc. Common Stock
Dermata Announces U.S. Trademark Registration for TOME(R)
accessnewswire.com
DRMA
Form 8-K
sec.gov
DRMA
Form 8-K
sec.gov
DRMA
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Third Quarter 2026
accessnewswire.com
DRMA
Form 8-K
sec.gov
DRMA
Dermata Advances Second Tome Skincare Product Toward Expected 2027 Launch with Initiation of Acne Clinical Trial
accessnewswire.com
DRMA
Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment
accessnewswire.com
DRMA
Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment
accessnewswire.com
DRMA
Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch
accessnewswire.com
DRMA
Form 8-K
sec.gov
DRMA
DRMAW